Literature DB >> 33347812

Infectivity of asymptomatic versus symptomatic COVID-19.

Andrew A Sayampanathan1, Cheryl S Heng2, Phua Hwee Pin2, Junxiong Pang3, Teoh Yee Leong4, Vernon J Lee3.   

Abstract

Entities:  

Year:  2020        PMID: 33347812      PMCID: PMC7836843          DOI: 10.1016/S0140-6736(20)32651-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Asymptomatic cases of COVID-19 are a potential source of substantial spread within the community setting. However, little information is available about the infectivity and epidemiological significance of people with asymptomatic COVID-19. Singapore's testing strategy for severe acute respiratory syndrome coronavirus 2 is designed to detect infection in both symptomatic and asymptomatic people. Various methods are used. Workers in specific industries, such as construction, marine, and process industries, are routinely tested once per week or every two weeks, and all close contacts of those who test positive for COVID-19 are tested as well. All COVID-19 case detection, regardless of symptom status, triggers public health actions, including contact tracing and the quarantining of close contacts. A close contact generally refers to a person who was within 2 m of the index case for at least 30 min (or for shorter durations in high-risk settings). All quarantined people are tested by PCR at the end of their quarantine period, and are only released from quarantine when they test negative for COVID-19. Serology tests are also done in most people who are infected, to determine the possible duration of their COVID-19 infection, and to assist with epidemiological investigations and containment efforts. As COVID-19 viral load is typically higher before seroconversion than after, seronegative cases are thought to be more infectious than seropositive cases.4, 5 To identify the relative infectivity of people with COVID-19 on the basis of their symptom and serology status, we studied all people who completed their quarantine between Aug 1 and Oct 11, 2020, as a result of being close community contacts of people who were infected and who had also undergone serology tests as part of their COVID-19 status assessment. Close contacts who lived in migrant worker dormitories were excluded from this analysis because their living environments were contextually different from community close contacts and because there were separate challenges in identifying cases and their close contacts within the dormitories. Negative binomial regression was done using Python version 3.7.1 (Python Software Foundation, Wilmington, DE, USA) to calculate the incidence rate ratios of a quarantined person from the community testing positive for COVID-19, adjusting for the symptom and serology status of the index case; two-tailed statistical significance was set at 0·05. 628 people with COVID-19 were included in this analysis (appendix). 3790 people were close contacts of an index case and were quarantined. On average, 6·0 people from the community were quarantined per index case. Overall, 89 (2%) of 3790 close community contacts developed COVID-19 while in quarantine. Of these, 50 (56%) of 89 contacts were quarantined because of an asymptomatic index case, whereas 39 (44%) contacts were quarantined because of a symptomatic case.43 (48%) contacts were quarantined because of a seronegative index case, whereas 46 (52%) were quarantined because of a seropositive index case. Negative binomial regression revealed that when adjusted for age, gender, and serology of index case, the incidence of COVID-19 among close contacts of a symptomatic index case was 3·85 times higher than for close contacts of an asymptomatic index case (95% CI2·06–7·19; p<0·0001; appendix). Our findings suggest that people with asymptomatic COVID-19 are infectious but might be less infectious than symptomatic cases. We also identified that the proportion of close contacts who became infected did not depend on the serology status of the index case. One reason for this observation could be that close contacts tend to live or work with the index case and are exposed because of their regular contact with a person who was infectious before turning seropositive. The main limitation of this analysis is that cycle threshold values and viable shedding data were not available for all individuals included. Future studies should explore the relationship between viral loads, viable shedding, and transmission. Nevertheless, these findings suggest that where resources permit, contact tracing should proactively seek people with asymptomatic COVID-19 because they can transmit disease and will need to be contained if a national policy objective is to minimise cases and transmission. However, if resources are limited, then focusing contact tracing around symptomatic people who are easy to identify (by way of them seeking health care) might be more resource-effective in reducing transmission at the population level.
  5 in total

Review 1.  Serology testing in the COVID-19 pandemic response.

Authors:  Rosanna W Peeling; Catherine J Wedderburn; Patricia J Garcia; Debrah Boeras; Noah Fongwen; John Nkengasong; Amadou Sall; Amilcar Tanuri; David L Heymann
Journal:  Lancet Infect Dis       Date:  2020-07-17       Impact factor: 25.071

2.  Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.

Authors:  Andreas Kronbichler; Daniela Kresse; Sojung Yoon; Keum Hwa Lee; Maria Effenberger; Jae Il Shin
Journal:  Int J Infect Dis       Date:  2020-06-17       Impact factor: 3.623

3.  Connecting clusters of COVID-19: an epidemiological and serological investigation.

Authors:  Sarah Ee Fang Yong; Danielle Elizabeth Anderson; Wycliffe E Wei; Junxiong Pang; Wan Ni Chia; Chee Wah Tan; Yee Leong Teoh; Priyanka Rajendram; Matthias Paul Han Sim Toh; Cuiqin Poh; Valerie T J Koh; Joshua Lum; Nur-Afidah Md Suhaimi; Po Ying Chia; Mark I-Cheng Chen; Shawn Vasoo; Benjamin Ong; Yee Sin Leo; Linfa Wang; Vernon J M Lee
Journal:  Lancet Infect Dis       Date:  2020-04-21       Impact factor: 25.071

4.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

5.  A study on infectivity of asymptomatic SARS-CoV-2 carriers.

Authors:  Ming Gao; Lihui Yang; Xuefu Chen; Yiyu Deng; Shifang Yang; Hanyi Xu; Zixing Chen; Xinglin Gao
Journal:  Respir Med       Date:  2020-05-13       Impact factor: 3.415

  5 in total
  54 in total

1.  Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination.

Authors:  Aaron Richterman; Eric A Meyerowitz; Muge Cevik
Journal:  Open Forum Infect Dis       Date:  2021-05-19       Impact factor: 3.835

2.  Control with uncertain data of socially structured compartmental epidemic models.

Authors:  Giacomo Albi; Lorenzo Pareschi; Mattia Zanella
Journal:  J Math Biol       Date:  2021-05-23       Impact factor: 2.259

3.  Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?

Authors:  Alexander B Beams; Rebecca Bateman; Frederick R Adler
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

4.  ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.

Authors:  Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Mayte Pérez-Olmeda; Miguel A Hernán; Jesús Oteo-Iglesias; Nerea Fernández de Larrea; Aurora Fernández-García; Mariano Martín; Pablo Fernández-Navarro; Israel Cruz; Jose L Sanmartín; Jose León Paniagua; Juan F Muñoz-Montalvo; Faustino Blanco; Raquel Yotti; Marina Pollán
Journal:  J Clin Epidemiol       Date:  2021-06-11       Impact factor: 6.437

5.  Modelling COVID-19 contagion: risk assessment and targeted mitigation policies.

Authors:  Rama Cont; Artur Kotlicki; Renyuan Xu
Journal:  R Soc Open Sci       Date:  2021-03-31       Impact factor: 2.963

6.  All five COVID-19 outbreaks during epidemic period of 2020/2021 in China were instigated by asymptomatic or pre-symptomatic individuals.

Authors:  Caixin Yang; Sihui Zhang; Shan Lu; Jing Yang; Yanpeng Cheng; Yue Liu; Lijun Zhao; Jian Gong; Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2021-05-21

Review 7.  Misdiagnosis of SARS-CoV-2: A Critical Review of the Influence of Sampling and Clinical Detection Methods.

Authors:  Daniel Keaney; Shane Whelan; Karen Finn; Brigid Lucey
Journal:  Med Sci (Basel)       Date:  2021-05-25

8.  Role of meteorological factors in the transmission of SARS-CoV-2 in the United States.

Authors:  Yiqun Ma; Sen Pei; Jeffrey Shaman; Robert Dubrow; Kai Chen
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 14.919

9.  Smartphone screen testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals.

Authors:  Rodrigo M Young; Camila J Solis; Andres Barriga-Fehrman; Carlos Abogabir; Alvaro R Thadani; Mariana Labarca; Eva Bustamante; Cecilia V Tapia; Antonia G Sarda; Francisca Sepulveda; Nadia Pozas; Leslie C Cerpa; María A Lavanderos; Nelson M Varela; Alvaro Santibañez; Ana M Sandino; Felipe Reyes-Lopez; Garth Dixon; Luis A Quiñones
Journal:  Elife       Date:  2021-06-22       Impact factor: 8.140

10.  Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.

Authors:  Ko Nakajo; Hiroshi Nishiura
Journal:  Theor Biol Med Model       Date:  2021-07-16       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.